Brenig Therapeutics
Phase 1Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases. Leveraging decades of drug development expertise and cutting-edge research enhanced by AI and machine learning, we are committed to delivering disease-modifying treatments that target the root causes of debilitating neurological conditions.
About
Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases. Leveraging decades of drug development expertise and cutting-edge research enhanced by AI and machine learning, we are committed to delivering disease-modifying treatments that target the root causes of debilitating neurological conditions.
Funding History
2Total raised: $69M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile